FDA Accepts Supplement for KEFLEX (Cephalexin) by PRAGMA
The FDA has accepted a supplemental application for KEFLEX (Cephalexin) from PRAGMA.
Asset / Drug
Drug and asset intelligence for PRAGMA with 4 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.